A guide to diagnosis and treatment of Leigh syndrome

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 3, 2014, Pages 257-265

  Baertling, Fabian ^a   Rodenburg, Richard J ^b   Schaper, Jörg ^a   Smeitink, Jan A ^b   Koopman, Werner J H ^b,c   Mayatepek, Ertan ^a   Morava, Eva ^b   Distelmaier, Felix ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CARNITINE; CREATINE; RIBOFLAVIN; THIAMINE; THIOCTIC ACID; UBIDECARENONE; VATIQUINONE;

CLINICAL EVALUATION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; FIBROBLAST CULTURE; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; LEIGH DISEASE; MEDICAL HISTORY; MUSCLE BIOPSY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW;

METABOLIC DISEASE; NEUROMUSCULAR; PAEDIATRIC;

ADOLESCENT; ADULT; AGE OF ONSET; BIOPSY; BRAIN; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DNA, MITOCHONDRIAL; GENETIC COUNSELING; HUMANS; LEIGH DISEASE; MAGNETIC RESONANCE IMAGING; MUSCLE, SKELETAL; NEUROIMAGING; YOUNG ADULT;

EID: 84896722661     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304426     Document Type: Review

References (99)

1. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216-21.
2. Feigin I, Wolf A. A disease in infants resembling chronic Wernicke's encephalopathy. J Pediatr 1954;45:243-63.
3. Hommes FA, Polman HA, Reerink JD. Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child 1968;43:423-6.
4. Farmer TW, Veath L, Miller AL, et al. Pyruvate decarboxylase deficiency in a patient with subacute necrotizing encephalopathy. Neurology (Minneap) 1973;23:429-33.
5. DeVivo DC, Haymond MW, Obert KA, et al. Defective activation of the pyruvate dehydrogenase complex in subacute necrotizing encephalomyelopathy (Leigh disease). Ann Neurol 1979;6:483-94. (Pubitemid 10174406)
6. Willems JL, Monnens LA, Trijbels JM, et al. Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 1977;60:850-7. (Pubitemid 8249270)
7. Jareno NM, Fernandez-Mayoralas DM, Silvestre CP, et al. 3-methylglutaconic aciduria type 4 manifesting as Leigh syndrome in 2 siblings. J Child Neurol 2007;22:218-21. (Pubitemid 46860424)
8. Salviati L, Freehauf C, Sacconi S, et al. Novel SURF1 mutation in a child with subacute encephalopathy and without the radiological features of Leigh Syndrome. Am J Med Genet A 2004;128A:195-8. (Pubitemid 39162947)
9. Dahl HH. Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome. Am J Hum Genet 1998;63:1594-7.
10. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol 2008;39:223-35.
11. Van Maldergem L, Trijbels F, DiMauro S, et al. Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 2002;52:750-4. (Pubitemid 35403184)
12. Wijburg FA, Barth PG, Bindoff LA, et al. Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics 1992;23:147-52.
13. Janssen AJ, Smeitink JA, van den Heuvel LP. Some practical aspects of providing a diagnostic service for respiratory chain defects. Ann Clin Biochem 2003;40:3-8. (Pubitemid 36051404)
14. Distelmaier F, Koopman WJ, van den Heuvel LP, et al. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 2009;132:833-42.
15. Leshinsky-Silver E, Lev D, Malinger G, et al. Leigh disease presenting in utero due to a novel missense mutation in the mitochondrial DNA-ND3. Mol Genet Metab 2010;100:65-70.
16. Willemsen M, Rodenburg RJ, Teszas A, et al. Females with PDHA1 gene mutations: a diagnostic challenge. Mitochondrion 2006;6:155-9. (Pubitemid 43890604)
17. Ostergaard E, Bradinova I, Ravn SH, et al. Hypertrichosis in patients with SURF1 mutations. Am J Med Genet A 2005;138:384-8. (Pubitemid 41532959)
18. Baertling F, Mayatepek E, Distelmaier F. Hypertrichosis in presymptomatic mitochondrial disease. J Inherit Metab Dis. Published Online First: 14 February 2013. doi: 10.1007/s105450-013-9593-3
19. Debray FG, Lambert M, Allard P, et al. Low citrulline in Leigh disease: still a biomarker of maternally inherited Leigh syndrome. J Child Neurol 2010;25:1000-2.
20. Rodenburg RJ. Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis 2010;34:283-92.
21. Drousiotou A, DiMeo I, Mineri R, et al. Ethylmalonic encephalopathy: application of improved biochemical and molecular diagnostic approaches. Clin Genet 2011;79:385-90.
22. Wortmann SB, Kluijtmans LA, Rodenburg RJ, et al. 3-Methylglutaconic aciduria-lessons from 50 genes and 977 patients. J Inherit Metab Dis. Published Online First: 25 January 2013. doi: 10.1007/s10545-012-9579-6
23. Wortmann SB, Vaz FM, Gardeitchik T, et al. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 2012;44:797-802.
24. Morava E, Steuerwald U, Carrozzo R, et al. Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. Mitochondrion 2009;9:438-42.
25. Suomalainen A, Elo JM, Pietilainen KH, et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 2011;10:806-18.
26. Medina L, Chi TL, DeVivo DC, et al. MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect. AJR Am J Roentgenol 1990;154:1269-74. (Pubitemid 20179479)
27. Valanne L, Ketonen L, Majander A, et al. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998;19:369-77. (Pubitemid 30413811)
28. Friedman SD, Shaw DW, Ishak G, et al. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010;16:129-35.
29. Herzer M, Koch J, Prokisch H, et al. Leigh disease with brainstem involvement in complex I deficiency due to assembly factor NDUFAF2 defect. Neuropediatrics 2010;41:30-4.
30. Lebre AS, Rio M, d'Arcier L Faivre, et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet 2011;48:16-23.
31. Rossi A, Biancheri R, Bruno C, et al. Leigh Syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings. AJNR Am J Neuroradiol 2003;24:1188-91. (Pubitemid 36734249)
32. Zafeiriou DI, Koletzko B, Mueller-Felber W, et al. Deficiency in complex IV (cytochrome c oxidase) of the respiratory chain, presenting as a leukodystrophy in two siblings with Leigh syndrome. Brain Dev 1995;17:117-21.
33. Scaglia F, Wong LJ, Vladutiu GD, et al. Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects. AJNR Am J Neuroradiol 2005;26:1675-80. (Pubitemid 43853662)
34. Kumakura A, Asada J, Okumura R, et al. Diffusion-weighted imaging in preclinical Leigh syndrome. Pediatr Neurol 2009;41:309-11.
35. Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 2003;24:33-41. (Pubitemid 36110098)
36. Sijens PE, Smit GP, Rodiger LA, et al. MR spectroscopy of the brain in Leigh syndrome. Brain Dev 2008;30:579-83.
37. Kinghorn KJ, Kaliakatsos M, Blakely EL, et al. Hypertrophic olivary degeneration on magnetic resonance imaging in mitochondrial syndromes associated with POLG and SURF1 mutations. J Neurol 2013;260:3-9.
38. van den Heuvel LP, Smeitink JA, Rodenburg RJ. Biochemical examination of fibroblasts in the diagnosis and research of oxidative phosphorylation (OXPHOS) defects. Mitochondrion 2004;4:395-401. (Pubitemid 39646793)
39. Morava E, van den Heuvel L, Hol F, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006;67:1823-6. (Pubitemid 44900760)
40. Wolf NI, Smeitink JA. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002;59:1402-5. (Pubitemid 35285994)
41. Janssen AJ, Trijbels FJ, Sengers RC, et al. Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology. Clin Chem 2006;52:860-71. (Pubitemid 43673265)
42. Chazotte B, Vanderkooi G. Multiple sites of inhibition of mitochondrial electron transport by local anesthetics. Biochim Biophys Acta 1981;636:153-61. (Pubitemid 11001815)
43. Naito E, Ito M, Yokota I, et al. Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiency. J Neurol Sci 2002;201:33-7. (Pubitemid 34876902)
44. Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med 2012;366:1132-41.
45. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-3. (Pubitemid 120015131)
46. Kobayashi Y, Momoi MY, Tominaga K, et al. A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990;173:816-22.
47. Holt IJ, Harding AE, Petty RK, et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-33.
48. Mayr JA, Haack TB, Graf E, et al. Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am J Hum Genet 2012;90:314-20.
49. Milone M, Massie R. Polymerase gamma 1 mutations: clinical correlations. Neurologist 2010;16:84-91.
50. Naess K, Freyer C, Bruhn H, et al. MtDNA mutations are a common cause of severe disease phenotypes in children with Leigh syndrome. Biochim Biophys Acta 2009;1787:484-90.
51. Haack TB, Danhauser K, Haberberger B, et al. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 2010;42:1131-4.
52. Tucker EJ, Hershman SG, Kohrer C, et al. Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. Cell Metab 2011;14:428-34.
53. Nelen M, Veltman JA. Genome and exome sequencing in the clinic: unbiased genomic approaches with a high diagnostic yield. Pharmacogenomics 2012;13:511-14.
54. McKelvie P, Infeld B, Marotta R, et al. Late-adult onset Leigh syndrome. J Clin Neurosci 2012;19:195-202.
55. Gray F, Louarn F, Gherardi R, et al. Adult form of Leigh's disease: a clinico pathological case with CT scan examination. J Neurol Neurosurg Psychiatry 1984;47:1211-15. (Pubitemid 15204535)
56. Malojcic B, Brinar V, Poser C, et al. An adult case of Leigh disease. Clin Neurol Neurosurg 2004;106:237-40. (Pubitemid 38716153)
57. Wick R, Scott G, Byard RW. Mechanisms of unexpected death and autopsy findings in Leigh syndrome (subacute necrotising encephalomyelopathy). J Forensic Leg Med 2007;14:42-5. (Pubitemid 44942981)
58. Ulrich J, Fankhauser-Mauri C. Subacute necrotizing encephalopathy (Leigh) in an adult. Eur Neurol 1978;17:241-6. (Pubitemid 9019260)
59. Nagashima T, Mori M, Katayama K, et al. Adult Leigh syndrome with mitochondrial DNA mutation at 8993. Acta Neuropathol 1999;97:416-22. (Pubitemid 29134524)
60. Goldenberg PC, Steiner RD, Merkens LS, et al. Remarkable improvement in adult Leigh syndrome with partial cytochrome c oxidase deficiency. Neurology 2003;60:865-8. (Pubitemid 36297376)
61. Ronchi D, Bordoni A, Cosi A, et al. Unusual adult-onset Leigh syndrome presentation due to the mitochondrial m.9176T>C mutation. Biochem Biophys Res Commun 2011;412:245-8.
62. Marina AD, Schara U, Pyle A, et al. NDUFS8-related complex I deficiency extends phenotype from "PEO Plus" to Leigh syndrome. JIMD Rep 2013;10:17-22.
63. Piekutowska-Abramczuk D, Magner M, Popowska E, et al. SURF1 missense mutations promote a mild Leigh phenotype. Clin Genet 2009;76:195-204.
64. Counsell SJ, Tranter SL, Rutherford MA. Magnetic resonance imaging of brain injury in the high-risk term infant. Semin Perinatol 2010;34:67-78.
65. Manchanda S, Prasad A, Baruah BP. MRI findings in kernicterus. Indian J Pediatr 2013;80:181-2.
66. Zuccoli G, Siddiqui N, Bailey A, et al. Neuroimaging findings in pediatric Wernicke encephalopathy: a review. Neuroradiology 2010;52:523-9.
67. Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR Am J Roentgenol 2009;192:501-8.
68. Michel SJ, Given CA II, Robertson WC Jr. Imaging of the brain, including diffusion-weighted imaging in methylmalonic acidemia. Pediatr Radiol 2004;34:580-2. (Pubitemid 38967802)
69. McNeill A, Chinnery PF. Neurodegeneration with brain iron accumulation. Handb Clin Neurol 2011;100:161-72.
70. Sefidbakht S, Rasekhi AR, Kamali K, et al. Methanol poisoning: acute MR and CT findings in nine patients. Neuroradiology 2007;49:427-35. (Pubitemid 46951328)
71. Tabarki B, Al-Shafi S, Al-Shahwan S, et al. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. Neurology 2013;80:261-7.
72. Thorburn DR, Dahl HH. Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options. Am J Med Genet 2001;106:102-14.
73. Bredenoord AL, Pennings G, Smeets HJ, et al. Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update 2008;14:83-94.
74. White SL, Collins VR, Wolfe R, et al. Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. Am J Hum Genet 1999;65:474-82. (Pubitemid 30463005)
75. Niers L, van den Heuvel L, Trijbels F, et al. Prerequisites and strategies for prenatal diagnosis of respiratory chain deficiency in chorionic villi. J Inherit Metab Dis 2003;26:647-58. (Pubitemid 38008969)
76. Schuelke M, Detjen A, van den Heuvel L, et al. New nuclear encoded mitochondrial mutation illustrates pitfalls in prenatal diagnosis by biochemical methods. Clin Chem 2002;48:772-5. (Pubitemid 34439112)
77. Pfeffer G, Majamaa K, Turnbull DM, et al. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2012;(4):CD004426.
78. Morava E, Rodenburg R, van Essen HZ, et al. Dietary intervention and oxidative phosphorylation capacity. J Inherit Metab Dis 2006;29:589.
79. Tarnopolsky MA. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev 2008;60:1561-7.
80. Debs R, Depienne C, Rastetter A, et al. Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. Arch Neurol 2010; 67:126-30.
81. Gerards M, Kamps R, van Oevelen J, et al. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome. Brain 2013;136:882-90.
82. Enns GM, Kinsman SL, Perlman SL, et al. Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol Genet Metab 2012;105: 91-102.
83. Haginoya K, Miyabayashi S, Kikuchi M, et al. Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study. J Neurol Sci 2009;278:112-14.
84. Hirano M, Garone C, Quinzii CM. CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim Biophys Acta 2012;1820:625-31.
85. Di Rocco M, Lamba LD, Minniti G, et al. Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency. Eur J Paediatr Neurol 2000;4:115-17. (Pubitemid 30340610)
86. Komura K, Nakano K, Ishigaki K, et al. Creatine monohydrate therapy in a Leigh syndrome patient with A8344G mutation. Pediatr Int 2006;48:409-12. (Pubitemid 44127894)
87. Pinard JM, Marsac C, Barkaoui E, et al. Leigh syndrome and leukodystrophy due to partial succinate dehydrogenase deficiency: regression with riboflavin. Arch Pediatr 1999;6:421-6.
88. Toth G, Morava E, Bene J, et al. Carnitine-responsive carnitine insufficiency in a case of mtDNA 8993T>C mutation associated Leigh syndrome. J Inherit Metab Dis 2001;24:421-2. (Pubitemid 32677529)
89. Wang SB, Weng WC, Lee NC, et al. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy. Pediatr Neonatol 2008;49:145-9.
90. Mermigkis C, Bouloukaki I, Mastorodemos V, et al. Medical treatment with thiamine, coenzyme Q, vitamins E and C, and carnitine improved obstructive sleep apnea in an adult case of Leigh disease. Sleep Breath. Published Online First: 7 February 2013. doi: 10.1007/s11325-013-0816-5
91. Singh RB, Niaz MA. Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role. Int J Cardiol 1999;68:23-9. (Pubitemid 29083362)
92. Horvath R, Gorman G, Chinnery PF. How can we treat mitochondrial encephalomyopathies? Approaches to therapy. Neurotherapeutics 2008;5:558-68.
93. Gerards M, van den Bosch BJ, Danhauser K, et al. Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. Brain 2011;134:210-19.
94. Nouws J, Nijtmans LG, Smeitink JA, et al. Assembly factors as a new class of disease genes for mitochondrial complex I deficiency: cause, pathology and treatment options. Brain 2012;135:12-22.
95. Wexler ID, Hemalatha SG, McConnell J, et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 1997;49:1655-61.
96. de Meer K, Roef MJ, de Klerk JB, et al. Increasing fat in the diet does not improve muscle performance in patients with mitochondrial myopathy due to complex I deficiency. J Inherit Metab Dis 2005;28:95-8. (Pubitemid 40253988)
97. Laugel V, This-Bernd V, Cormier-Daire V, et al. Early-onset ophthalmoplegia in Leigh-like syndrome due to NDUFV1 mutations. Pediatr Neurol 2007; 36:54-7. (Pubitemid 46427784)
98. Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics 2007;119:535-43. (Pubitemid 46407550)
99. Stacpoole PW, Kerr DS, Barnes C, et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 2006; 117:1519-31. (Pubitemid 46071378)